Table 1.
The Susceptibility of Carbapenem-Resistant P. Aeruginosa Isolates to the Different Antimicrobial Agents
| Isolate N(%) |
ST | No (%) | Selected Antimicrobial Agents | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Piperacillin N(%) |
Ceftazidime N(%) |
Cefepime N(%) |
Aztreonam N(%) |
Piperacillin/Tazobactam N(%) |
Gentamicin N(%) |
Tobramycin N(%) |
Amikacin N(%) |
Ciprofloxacin N(%) |
|||
| CRPA 38 (55.88) |
235 | 14 (37.0) | 14 (100) | 14 (100) | 14 (100) | 14 (100) | 14 (100) | 14 (100) | 11 (78.5) | 6 (42.8) | 14 (100) |
| 357 | 8 (21.0) | 8 (100) | 8 (100) | 8 (100) | 8 (100) | 8 (100) | 8 (100) | 5 (62.5) | 5 (62.5) | 8 (100) | |
| 175 | 4 (10.5) | 4 (100) | 4 (100) | 3 (75) | 4 (100) | 3 (75) | 4 (100) | 1 (25) | 1 (25) | 3 (75) | |
| 111 | 4 (10.5) | 4 (100) | 4 (100) | 4 (100) | 4 (100) | 4 (100) | 4 (100) | 1 (25) | 1 (25) | 4 (100) | |
| 253 | 2 (5.3) | 2 (100) | 1 (50) | 0 | 0 | 0 | 2 (100) | 0 | 0 | 0 | |
| 360 | 2 (5.3) | 0 | 0 | 0 | 0 | 0 | 2 (100) | 0 | 0 | 0 | |
| 773 | 1 (2.6) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 | 0 | 0 | |
| 207 | 1 (2.6) | 0 | 1 (100) | 1 (100) | 0 | 0 | 1 (100) | 0 | 0 | 0 | |
| 823 | 1 (2.6) | 1 (100) | 1 (100) | 1 (100) | 0 | 1 (100) | 1 (100) | 0 | 0 | 1 (100) | |
| 861 | 1 (2.6) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 | 0 | 1 (100) | |
| Total N(%) | 35 (92.1) | 36 (92.1) | 33 (86.8) | 32 (84.2) | 32 (84.2) | 38 (100) | 18 (47.3) | 13 (34.2) | 31 (81.5) | ||
| Non-CRPA 30 (44.12) |
253 | 13 (43.3) | 8 (61.5) | 8 (61.5) | 4 (30.7) | 4 (30.7) | 4 (30.7) | 11 (84.6) | 4 (30.7) | 3 (23.0) | 4 (30.7) |
| 360 | 9 (30.0) | 0 | 0 | 0 | 0 | 0 | 6 (66.6) | 0 | 0 | 0 | |
| 446 | 8 (26.7) | 3 (33.3) | 3 (33.3) | 1 (12.5) | 1 (12.5) | 1 (12.5) | 5 (62.5) | 1 (12.5) | 1 (12.5) | 1 (12.5) | |
| Total N(%) | 11 (36.6) | 11 (36.6) | 5 (16.6) | 5 (16.6) | 5 (16.6) | 22 (73.3) | 5 (16.6) | 4 (13.3) | 5 (16.6) | ||
Abbreviations: CRPA, carbapenem-resistant P. aeruginosa; CSPA, carbapenem-susceptible P. aeruginosa; ST, sequence type based on MLST analysis.